Evidence for Encapsidation of Prokaryotic Sequences during Recombinant Adeno-Associated Virus Production and Their in Vivo Persistence after Vector Delivery-Reference-Cited by-同舟云学术

Evidence for Encapsidation of Prokaryotic Sequences during Recombinant Adeno-Associated Virus Production and Their in Vivo Persistence after Vector Delivery

Published:2005-10 Issue:4 Volume:12 Page:744-753
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Chadeuf Gilliane,Ciron Carine,Moullier Philippe,Salvetti Anna

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference37 articles.

1. Biology of adeno-associated virus;Berns;Curr. Top. Microbiol. Immunol.,1996

2. AAV DNA replication, integration and genetics;Carter,1990

3. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression;Samulski;J. Virol.,1989

4. Production of recombinant adeno-associated viral vectors;Snyder,1996

5. Novel tools for production and purification of recombinant adeno-associated virus vectors;Grimm;Hum. Gene Ther.,1998

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A self-complementary AAV proviral plasmid that reduces cross-packaging and ITR promoter activity in AAV vector preparations;Molecular Therapy - Methods & Clinical Development;2024-09

2. Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects;Biomedicines;2024-07-09

3. Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene Transfer;Human Gene Therapy;2024-07-01

4. Separation of full, empty, and partial adeno-associated virus capsids via anion-exchange chromatography with continuous recycling and accumulation;Journal of Chromatography B;2024-07

5. Producing high-quantity and high-quality recombinant adeno-associated virus by low-cis triple transfection;Molecular Therapy - Methods & Clinical Development;2024-06